Michael Wyzga Insider Profile

4 Followers
Michael Wyzga, Director at Exact Sciences, holds 11.47K shares in Exact Sciences (Ticker: EXAS), holds ― shares in Logicbio Therapeutics (Ticker: LOGC), holds ― shares in X4 Pharmaceuticals (Ticker: XFOR).
tipranks
Michael Wyzga

Michael Wyzga
Exact Sciences (EXAS)
Director

Not Ranked
Michael Wyzga has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
99.63%
0.37%
0.00%
0.00%
0.00% Others
A breakdown of Michael Wyzga's holdings

Insider Roles

Exact Sciences
(EXAS)
Director
Akebia Therapeutics
(AKBA)
Director
Logicbio Therapeutics
(LOGC)
Director
X4 Pharmaceuticals
(XFOR)
Director
+1 other positions
Roles that Michael Wyzga holds in companies

Most Profitable Insider Trade

Stock:
Akebia Therapeutics
(AKBA)
Rating:Informative Buy
Date:Mar 27, 2014 - Mar 27, 2015
Return:-46.10%
The most profitable trade made by Michael Wyzga

Michael Wyzga's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Exact Sciences
Jul 24, 2020
Director
Uninformative Buy
$1.36M
Logicbio Therapeutics
Director
X4 Pharmaceuticals
Director
Akebia Therapeutics
Mar 27, 2014
Director
Informative Buy
25.50K
$5.08K
OMED
OncoMed Pharma
$0.00
Radius Health
Chief Executive Officer, Director
IDIX
Idenix Pharma
List of latest transactions for each holding click on a transaction to see Michael Wyzga's performance on stock

Michael Wyzga insider profile FAQ

What is the percentage of profitable transactions made by Michael Wyzga?
The percentage of profitable transactions made by Michael Wyzga is ―.
    What is the average return per transaction made by Michael Wyzga?
    The average return per transaction made by Michael Wyzga is ―.
      What stocks does Michael Wyzga hold?
      Michael Wyzga holds: EXAS, LOGC, XFOR, AKBA, OMED, RDUS, IDIX stocks.
        What was Michael Wyzga’s latest transaction?
        Michael Wyzga latest transaction was an Uninformative Buy of ―.
          What was Michael Wyzga's most profitable transaction?
          Michael Wyzga’s most profitable transaction was an Informative Buy of AKBA stock on March 27, 2014. The return on the trade was -46.10%.
            What is Michael Wyzga's role in Exact Sciences?
            Michael Wyzga's role in Exact Sciences is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.